Otsuka Slaps Amneal With IP Suit Over Generic Abilify
Japanese drugmaker Otsuka Pharmaceuticals Co. Ltd. on Thursday launched a patent infringement suit against Amneal Pharmaceuticals LLC, challenging the rival's attempt to score U.S. approval of a generic version of anti-psychotic...To view the full article, register now.
Already a subscriber? Click here to view full article